beta

ADCT

ADC Therapeutics SA

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

ADC Therapeutics SA is a clinical-stage biotechnology company, which develops antibody drug conjugates. Its products include Lonca, Cami and ADCT-602. Its drugs are used in treating various advanced solid tumors. The company was founded on June 6, 2011 and is headquartered in Epalinges, Switzerland.

Market Cap: 2.8 Billion

Primary Exchange: New York Stock Exchange

Website: http://www.adctherapeutics.com

Shares Outstanding: 70.7 Million

Float: 34.3 Million

Dividend: (%)

Beta: 0.476224070994837

Sector: Health Technology

Industry: Pharmaceuticals: Major

Ethical Flags

Longest drawdown: 31 trading days

From: 2020-07-02 To: 2020-08-14

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud